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Abstract
Introduction
• Prevalence of MDD in the U.S. is 7%, lifetime prevalence is 
16.6%
• MDD is a purely clinical diagnosis based on patient history 
and symptoms
• Hypotheses regarding the pathogenesis of depression:
– An imbalance in the hormones serotonin, tryptophan, 
noradrenaline, and dopamine
– Areas of the brain that show functional and structural 
abnormalities include anterior cingulate, orbitofrontal 
cortex, amygdala and basal ganglia, hippocampus, 
prefrontal cortex, ventral striatum, hypothalamic 
pituitary adrenal axis, and the nucleus accumbens 
Research Question & Analysis




• One pitfall to many of the studies is that they excluded patients 
with MDD who were already living active life style and 
exercising; also, participants had to be willing to participate in 
an exercise regimen
• The study where participants got to choose their own intensity 
of exercise showed benefit, which is useful to know
• One study did show that the most effective dose for treatment 
in MDD is 30 minutes 3 times per week, which is not a very 
high number and may make exercise a more attractive 
treatment option for patients
• More adverse effects were seen in patients treated with 
pharmacotherapy versus exercise therapy
• Antidepressants such as sertraline are given a warning that they 
take weeks to months to take effect; therefore, starting patients 
on an exercise regimen at the same time as medication 
administration may result in a quicker improvement of 
depression symptoms
Objective
The purpose of this systematic literature review is to 
determine how exercise can be incorporated into the 
treatment of major depressive disorder (MDD) and its 
efficacy. 
Methods
In this review, four databases were searched including 
SportDiscus, Pubmed, Cochrane Database of Systematic 
Reviews, and PsycInfo from October 1 to January 5, 2018. A 
variety of key terms were used when searching. Works 
chosen for review were published after the year 2000, were 
peer reviewed, and included randomized control trials 
(RCTs), pilot studies, systematic reviews, and meta-analyses. 
Sources that were excluded included those published prior 
to the year 2000, had poor study design, and included 
comorbid psychiatric conditions varying from MDD. 
Results
For this review, 17 resources were selected. Much of the 
research presented shows evidence for the use of exercise in 
the treatment of MDD. However, most of the research points 
to exercise as more of a beneficial augmentation strategy for 
MDD versus a first line therapy involving pharmacotherapy 
with selective serotonin reuptake inhibitors (SSRIs) and 
psychotherapy in disease treatment. 
Conclusion 
Current research on the topic of exercise as therapy for 
MDD does show promise; however, more research still 
needs to be done in order to place exercise as an equivalent 
treatment to pharmacotherapy or psychotherapy. 
• What role exercise may have in the treatment of MDD?
–Type, duration, and frequency of exercise most efficacious 
for MDD treatment will be assessed
–Exercise will be compared to pharmacotherapy, 
psychotherapy, and exercise as augmentation to 
pharmacotherapy and/or psychotherapy
– It is expected that exercise therapy will have benefits over 
SSRIs and psychotherapy but will not necessarily be 
superior to the latter two
• A systematic literature review will look at efficacy of the 
three therapies in regard to access, adherence, remission, 
and improvement of symptoms
•Decreased hippocampal volume and function in MRI with 
increasing depressive episodes
•Theme one: Type of Exercise, Intensity, and Dose for 
Therapeutic Benefit
– Neither aerobic or resistance training are superior to each 
other
– Optimal therapeutic effect of exercise was 3 or more times per 
week for at least 30  minutes
– Cochrane review of 39 studies showed that mixed aerobic 
and anaerobic exercise was most beneficial in MDD treatment 
and it took 13 to 36 sessions in order to see a large effect
– Effect of exercise drops off after greater than 3 hours per week
– Discontinuation of exercise causes worsening of depressive 
symptoms – not curative
•Theme two:  Exercise Compared to SSRIs and Psychotherapy
– Cochrane Review of 39 studies showed no significant 
difference comparing exercise to pharmacological and 
psychological treatment
– Physical exercise was compared to usual care and placebo
– Exercise compared to placebo showed a statistically 
significant improvement of depressive symptoms in mild to 
moderate MDD
•Theme three: Exercise as Adjunctive Therapy for Depression
– Partial responders to SSRIs were assigned either a high or low 
dose exercise regimen; results showed significant 
improvement of depressive symptoms and quality of life in 
both groups
– All participants were given 50 mg of sertraline and allowed to 
increase medication dose as needed; half of the participants 
were started on an exercise regimen as well; participants who 
were in the exercise group needed lower doses of sertraline 
but both groups had similar reduction in depressive symptoms
– A study by Murri et al., randomized participants to sertraline 
plus non-progressive exercise, sertraline plus progressive 
exercise, and sertraline alone; showing a much higher 
remission rate for those in either exercise group compared to 
sertraline alone 
• Exercise may play the best role as augmentation to 
psychotherapy or SSRIs pharmacotherapy as it relieves 
symptoms more rapidly than either of the two alone
• Starting patients on a mixed aerobic and resistance training 
program, 3 or more times per week is shown to be the most 
beneficial
• Patient empowerment is a major component to treating a 
patient; using exercise as a treatment gives the patients 
responsibility and control over their medical condition
• Concerns for using exercise as a therapy includes 
compliance, access, and ease of therapy; no doubt that 
taking a single pill daily is less time consuming than exercise
• Exercise has many other medical benefits including weight 
reduction, musculoskeletal strengthening, and cardiac 
conditioning 
• More research needs to be done on the topic of exercise in 
the treatment of MDD
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• 1st line treatment for MDD involves psychotherapy or 
pharmacotherapy with SSRIs
– Psychotherapy is difficult to access in rural areas with a 
shortage of trained counselors and psychiatrists
– 40% of patients treated with SSRIs do no respond to 
therapy
– Many patients treated with SSRIs complain of 
undesirable side effects
• Exercise is a potential benign, accessible, and affordable 
treatment option in mild to moderate MDD
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